In their desperation, doctors and patients have been using an array of antimicrobial products in a manner that will lead to more harm than good.
Date: April 1, 2020
Source: The Globe and Mail
Author: Andrew Morris and Gerry Wright
Excerpt: “Because COVID-19 is a viral infection that appears as either a mild cough or cold, a pneumonia or even severe sepsis, most patients will receive antibiotics during their treatment, often unnecessarily. As the documented global burden of coronavirus infections nears one million cases (and counting), the consumption of antibiotics will likely rise proportionately. We can safely predict that this will lead to a rise in antimicrobial resistance, which will affect all aspects of health care long after COVID-19 has left us. If there is no second wave of this drug-resistant virus, there will almost certainly be a second wave of drug-resistant bacteria.”